Thanks to our valued partner Seegene, who developed a test for the 2019-nCoV detection within a very short time, we were able to deliver already more than 30’000 COVID-19 tests.
- info@buhlmannlabs.ch
- +41 61 487 12 12
News
BÜHLMANN is proud to add Quantum Blue® Anti-Infliximab (RUO) and Quantum Blue® Anti-Adalimumab (RUO) to the TDM rapid test portfolio.
A French medical TV show presented a story about how healthcare professionals and patients are using IBDoc®, the fecal calprotectin home test, to improve their control over the disease.
We announce a new partner channel agreement with Roche Diagnostics for the launch and distribution of the BÜHLMANN fCAL® turbo test.
Social Links